In the last trading session, 2.67 million TNF Pharmaceuticals Inc (NASDAQ:TNFA) shares changed hands as the company’s beta touched 1.97. With the company’s per share price at $0.37 changed hands at -$0.03 or -8.22% during last session, the market valuation stood at $1.02M. TNFA’s last price was a discount, traded about -845.95% off its 52-week high of $3.50. The share price had its 52-week low at $0.32, which suggests the last value was 13.51% up since then. When we look at TNF Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 2.12 million shares, with the 3-month average coming to 807.55K.

TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information

Instantly TNFA was in red as seen at the end of in last trading. With action 3.03%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -67.75%, with the 5-day performance at 3.03% in the green. However, in the 30-day time frame, TNF Pharmaceuticals Inc (NASDAQ:TNFA) is -8.87% down. Looking at the short shares, we see there were 0.78 million shares sold at short interest cover period of 1.18 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 67.29%.

TNFA Dividends

TNF Pharmaceuticals Inc is expected to release its next quarterly earnings report in May.

TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.59% of TNF Pharmaceuticals Inc shares while 15.10% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 15.19%.